Search filters

List of works by Wee Joo Chng

ADARs, RNA editing and more in hematological malignancies

scientific article published on 02 November 2020

Aberrant hyperediting of the myeloma transcriptome by ADAR1 confers oncogenicity and is a marker of poor prognosis

scientific article published on 30 July 2018

BET Bromodomain inhibition promotes De-repression of TXNIP and activation of ASK1-MAPK pathway in acute myeloid leukemia.

scientific article published on 11 July 2018

Bacterial Infection Among Patients With Multiple Myeloma Treated With Bortezomib-based Induction Therapy: Real-World Experience in an Asian Cancer Center

scientific article published on 09 January 2020

Carfilozomib versus bortezomib for relapsed or refractory myeloma – Authors' reply

scientific article published on 29 March 2016

Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study

scientific article

Carfilzomib and dexamethasone vs bortezomib and dexamethasone in patients with relapsed multiple myeloma: results of the phase 3 study ENDEAVOR (NCT01568866) according to age subgroup

scientific article

Carfilzomib or bortezomib in relapsed or refractory multiple myeloma (ENDEAVOR): an interim overall survival analysis of an open-label, randomised, phase 3 trial

scientific article published on 23 August 2017

Carfilzomib-Dexamethasone Versus Bortezomib-Dexamethasone in Relapsed or Refractory Multiple Myeloma: Updated Overall Survival, Safety, and Subgroups

scientific article published on 02 May 2019

Carfilzomib-dexamethasone versus subcutaneous or intravenous bortezomib in relapsed or refractory multiple myeloma: secondary analysis of the phase 3 ENDEAVOR study

scientific article published on 22 September 2017

Clinical implication of centrosome amplification in plasma cell neoplasm

scientific article published on 22 December 2005

Gene expression profiling and correlation with outcome in clinical trials of the proteasome inhibitor bortezomib

scientific article

Gene-expression profiling of Waldenstrom macroglobulinemia reveals a phenotype more similar to chronic lymphocytic leukemia than multiple myeloma

scientific article

Immunoglobulin M Paraproteinaemias

scientific article published on 25 June 2020

International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma

scientific article published on August 2016

International harmonization in performing and reporting minimal residual disease assessment in multiple myeloma trials

scientific article published on 11 August 2020

Macrophages protect mycoplasma-infected chronic myeloid leukemia cells from natural killer cell killing

scientific article published on 13 January 2020

Molecular Dissection of Hyperdiploid Multiple Myeloma by Gene Expression Profiling

article

Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer/T-cell lymphoma

scientific article published on 27 July 2018

Optimizing drug combinations against multiple myeloma using a quadratic phenotypic optimization platform (QPOP)

scientific article published on 01 August 2018

Perspectives on the Risk-Stratified Treatment of Multiple Myeloma

Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group

scientific article

STAT3: A Promising Therapeutic Target in Multiple Myeloma.

scientific article published on 26 May 2019

Targeting NF-κB Signaling for Multiple Myeloma

scientific article published on 06 August 2020

Tumor suppressor p16 methylation in multiple myeloma: biological and clinical implications

scientific article published on 13 July 2006

Paulina is supported by:

About Paulina

Help